These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22512656)

  • 1. Design, synthesis, and activity evaluation of a new 5-fluorouracil prodrug containing an Asn-Gly-Arg(NO2)COOCH3 tripeptide.
    Luan Y; Jing F; Zhang J; Zou M; Wang X; Jia Y; Liu N; Mou J; Xu W
    Protein Pept Lett; 2012 Oct; 19(10):1122-31. PubMed ID: 22512656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 13F-1, a novel 5-fluorouracil prodrug containing an Asn-Gly-Arg (NO2) COOCH3 tripeptide, inhibits human colonic carcinoma growth by targeting Aminopeptidase N (APN/CD13).
    Cui SX; Zhang HL; Xu WF; Qu XJ
    Eur J Pharmacol; 2014 Jul; 734():50-9. PubMed ID: 24726845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A doxorubicin-CNGRC-peptide conjugate with prodrug properties.
    van Hensbergen Y; Broxterman HJ; Elderkamp YW; Lankelma J; Beers JC; Heijn M; Boven E; Hoekman K; Pinedo HM
    Biochem Pharmacol; 2002 Mar; 63(5):897-908. PubMed ID: 11911842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A unified mechanism for aminopeptidase N-based tumor cell motility and tumor-homing therapy.
    Liu C; Yang Y; Chen L; Lin YL; Li F
    J Biol Chem; 2014 Dec; 289(50):34520-9. PubMed ID: 25359769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NGR (Asn-Gly-Arg)-targeted delivery of coagulase to tumor vasculature arrests cancer cell growth.
    Seidi K; Jahanban-Esfahlan R; Monhemi H; Zare P; Minofar B; Daei Farshchi Adli A; Farajzadeh D; Behzadi R; Mesgari Abbasi M; Neubauer HA; Moriggl R; Zarghami N; Javaheri T
    Oncogene; 2018 Jul; 37(29):3967-3980. PubMed ID: 29662195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of an aminopeptidase N-binding sequence to human endostatin improves inhibition of ovarian carcinoma growth.
    Yokoyama Y; Ramakrishnan S
    Cancer; 2005 Jul; 104(2):321-31. PubMed ID: 15952188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of BC-01, a novel mutual prodrug (hybrid drug) of ubenimex and fluorouracil as anticancer agent.
    Jiang Y; Li X; Hou J; Huang Y; Jia Y; Zou M; Zhang J; Wang X; Xu W; Zhang Y
    Eur J Med Chem; 2016 Oct; 121():649-657. PubMed ID: 27322756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.
    Pasqualini R; Koivunen E; Kain R; Lahdenranta J; Sakamoto M; Stryhn A; Ashmun RA; Shapiro LH; Arap W; Ruoslahti E
    Cancer Res; 2000 Feb; 60(3):722-7. PubMed ID: 10676659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the anti-cervical cancer effect of a prodrug ：CBZ-AAN-DOX with hypoxic cell culture and tumor-bearing zebrafish models.
    Chen HC; Rui W; You SY; Liu XW; Huang J; Chen HY
    Exp Cell Res; 2020 Jun; 391(1):111980. PubMed ID: 32229193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An antimicrobial peptide containing NGR motif has potent antitumor activity against CD13+ and CD13- tumor cells.
    Zhang Z; Hou L; Feng L; Huang S; Luo M; Shao S; Zhang X; Gu S; Zhao X
    Tumour Biol; 2015 Sep; 36(10):8167-75. PubMed ID: 25990455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NGR-modified micelles enhance their interaction with CD13-overexpressing tumor and endothelial cells.
    Wang X; Wang Y; Chen X; Wang J; Zhang X; Zhang Q
    J Control Release; 2009 Oct; 139(1):56-62. PubMed ID: 19470394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted antitumor prodrug therapy using CNGRC-yCD fusion protein in combination with 5-fluorocytosine.
    Li JJ; Chang SF; Liau II; Chan PC; Liu RS; Yen SH; Wang HE; Chang CA
    J Biomed Sci; 2016 Jan; 23():15. PubMed ID: 26801910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A CD13-targeting peptide integrated protein inhibits human liver cancer growth by killing cancer stem cells and suppressing angiogenesis.
    Zheng YB; Gong JH; Liu XJ; Li Y; Zhen YS
    Mol Carcinog; 2017 May; 56(5):1395-1404. PubMed ID: 27991698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation synergizes with antitumor activity of CD13-targeted tissue factor in a HT1080 xenograft model of human soft tissue sarcoma.
    Brand C; Greve B; Bölling T; Eich HT; Willich N; Harrach S; Hintelmann H; Lenz G; Mesters RM; Kessler T; Schliemann C; Berdel WE; Schwöppe C
    PLoS One; 2020; 15(2):e0229271. PubMed ID: 32084238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminopeptidase N (CD13) targeted MR and NIRF dual-modal imaging of ovarian tumor xenograft.
    Meng Y; Zhang Z; Liu K; Ye L; Liang Y; Gu W
    Mater Sci Eng C Mater Biol Appl; 2018 Dec; 93():968-974. PubMed ID: 30274135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vivo Tumor Growth Inhibition and Antiangiogenic Effect of Cyclic NGR Peptide-Daunorubicin Conjugates Developed for Targeted Drug Delivery.
    Tripodi AAP; Ranđelović I; Biri-Kovács B; Szeder B; Mező G; Tóvári J
    Pathol Oncol Res; 2020 Jul; 26(3):1879-1892. PubMed ID: 31820302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CNGRCLLII(KLAKLAK)2 peptide shows cytotoxicity against HUVECs by inducing apoptosis: An in vitro and in vivo study.
    Wang G; Yuan N; Huang S; Feng L; Han R; Zhang Y; Ren J; Meng M; Zhao X
    Tumour Biol; 2017 May; 39(5):1010428317701649. PubMed ID: 28475015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy.
    Liu YR; Guan YY; Luan X; Lu Q; Wang C; Liu HJ; Gao YG; Yang SC; Dong X; Chen HZ; Fang C
    Biomaterials; 2015 Feb; 42():161-71. PubMed ID: 25542804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel alkylating prodrug melflufen (J1) inhibits angiogenesis in vitro and in vivo.
    Strese S; Wickström M; Fuchs PF; Fryknäs M; Gerwins P; Dale T; Larsson R; Gullbo J
    Biochem Pharmacol; 2013 Oct; 86(7):888-95. PubMed ID: 23933387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NGR Tumor-Homing Peptides: Structural Requirements for Effective APN (CD13) Targeting.
    Graziadio A; Zanda M; Frau S; Fleming IN; Musolino M; Dall'Angelo S; Baldassarre M; Piras M
    Bioconjug Chem; 2016 May; 27(5):1332-40. PubMed ID: 27077642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.